BioCatalyst

Cetrelimab, Amivantamab — catalyst calendar

1 verified catalyst event(s) referencing Cetrelimab, Amivantamab, each linked to its official source. Verified as of 2026-10-02.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01-31
in 4mo
ESTIMATED
 READOUT
A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants W
Phase 1/2 · Carcinoma, Non-Small-Cell Lung
 Janssen Research & Development, LL Cetrelimab, Amivantamab ClinicalTrials.gov ↗
✓ Source-checked 2026-10-02
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.